Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentric Randomized Study of H. Pylori Eradication and Pepsinogen Testing for Prevention of Gastric Cancer Mortality

NCT02047994 is registered in ClinicalTrials.gov with International Agency for Research on Cancer as lead sponsor.

NCT NCT02047994
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02047994 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentric Randomized Study of H. Pylori Eradication and Pepsinogen Testing for Prevention of Gastric Cancer Mortality
Lead sponsor
International Agency for Research on Cancer
Phase
Phase 4
Overall status
Recruiting
Start date
March 31, 2013
Completion date
December 31, 2035
Enrollment
30,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrophic gastritis, gastric cancer, helicobacter pylori infections